Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 2, 2007

Eisai Licenses Data Analysis System from Rosetta Biosoftware

  • Eisai licensed Rosetta Biosoftware’s Elucidator® system for differential protein expression analysis and biomarker discovery.

    "The Elucidator system will be an important tool for enabling quantitative methods and characterizing cancer proteomes by multidimensional LC-MS/MS," says Yoshiya Oda, Ph.D., senior scientist at the Laboratory of Seeds Finding Technology. Eisai will use the Elucidator system to help identify potential neurology biomarkers.

    According to Rosetta Biosoftware, the Elucidator system supports end-to-end data management and analysis workflow for comparative proteomics. It provides multiple ways to analyze and refine data.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »